An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma.

摘要: Background Feeding jejunostomy tubes (J-tube) are often placed during gastrectomy for cancer to decrease malnutrition and promote delivery of adjuvant therapy. We hypothesized that J-tubes actually associated with increased complications do not improve nutritional status nor increase rates therapy. Methods One hundred thirty-two patients were identified from a prospectively maintained database underwent gastric resection adenocarcinoma between 1/00 3/11 at one institution. Pre- postoperative relevant intraoperative parameters examined. Results Median age was 64 years (range 23–85). Forty-six (35%) total 86 (65%) subtotal gastrectomy. in 66 (50%) patients, 34 whom 32 Preoperative similar J-tube no groups as measured by serum albumin (3.5 vs. 3.4 g/dL). Tumor grade, T, N, overall stage groups. placement postop (59% 41%, P = 0.04) infectious (36% 17%, P = 0.01), which majority surgical site infections. prolonged length stay (13 11 days; P = 0.05). There difference 30, 60, 90-day levels the rate receiving therapy (J-tube: 61%, J-tube: 53%, P = 0.38). Multivariate analyses revealed be (HR: 4.8; 95% CI: 1.3–17.7; P = 0.02), even when accounting tumor operative difficulty extent. Subset analysis have less morbidity after gastrectomy. Conclusion J-tube may demonstrable advantage Routine use justified, but selectively indicated undergoing A prospective trial is needed validate these results. J. Surg. Oncol. 2013;107:728–734. © 2013 Wiley Periodicals, Inc.